vs
Side-by-side financial comparison of Astria Therapeutics, Inc. (ATXS) and TMC the metals Co Inc. (TMC). Click either name above to swap in a different company.
TMC the metals Co Inc. is the larger business by last-quarter revenue ($1.3M vs $706.0K, roughly 1.8× Astria Therapeutics, Inc.). TMC the metals Co Inc. runs the higher net margin — -3136.5% vs -4482.0%, a 1345.5% gap on every dollar of revenue.
Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel targeted therapies for rare hematological and allergic diseases with high unmet medical needs. Its core pipeline includes drug candidates designed to address life-threatening immune-mediated conditions, serving patient populations across North America and other global markets with limited existing treatment options.
The Metals Company, formerly DeepGreen Metals, is a Canadian deep sea mining exploration company. The company focuses on the mining of polymetallic nodules in the Clarion Clipperton Zone of the Pacific.
ATXS vs TMC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $706.0K | $1.3M |
| Net Profit | $-31.6M | $-40.4M |
| Gross Margin | — | — |
| Operating Margin | -4830.6% | -3470.9% |
| Net Margin | -4482.0% | -3136.5% |
| Revenue YoY | — | 2425.5% |
| Net Profit YoY | -29.0% | -151.5% |
| EPS (diluted) | $-0.55 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.3M | ||
| Q3 25 | $706.0K | $1.3M | ||
| Q3 24 | $0 | — | ||
| Q4 23 | — | $205.0K | ||
| Q3 23 | — | $319.0K | ||
| Q1 23 | — | $454.0K | ||
| Q4 22 | — | $567.0K | ||
| Q3 22 | — | $352.0K |
| Q4 25 | — | $-40.4M | ||
| Q3 25 | $-31.6M | $-184.5M | ||
| Q3 24 | $-24.5M | — | ||
| Q4 23 | — | $-33.5M | ||
| Q3 23 | — | $-12.5M | ||
| Q1 23 | — | $-13.7M | ||
| Q4 22 | — | $-109.6M | ||
| Q3 22 | — | $-27.9M |
| Q4 25 | — | -3470.9% | ||
| Q3 25 | -4830.6% | -4134.4% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | -16223.9% | ||
| Q3 23 | — | -3924.1% | ||
| Q1 23 | — | -2947.8% | ||
| Q4 22 | — | -19625.2% | ||
| Q3 22 | — | -8127.0% |
| Q4 25 | — | -3136.5% | ||
| Q3 25 | -4482.0% | -13780.2% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | -16321.5% | ||
| Q3 23 | — | -3908.2% | ||
| Q1 23 | — | -3028.2% | ||
| Q4 22 | — | -19324.3% | ||
| Q3 22 | — | -7924.4% |
| Q4 25 | — | $0.11 | ||
| Q3 25 | $-0.55 | $0.46 | ||
| Q3 24 | $-0.42 | — | ||
| Q4 23 | — | $0.12 | ||
| Q3 23 | — | $0.04 | ||
| Q1 23 | — | $0.05 | ||
| Q4 22 | — | $0.45 | ||
| Q3 22 | — | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $227.7M | $117.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $233.3M | $-33.4M |
| Total Assets | $271.9M | $181.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $117.6M | ||
| Q3 25 | $227.7M | $115.6M | ||
| Q3 24 | $344.3M | — | ||
| Q4 23 | — | $6.8M | ||
| Q3 23 | — | $22.5M | ||
| Q1 23 | — | $28.4M | ||
| Q4 22 | — | $46.9M | ||
| Q3 22 | — | $66.9M |
| Q4 25 | — | $-33.4M | ||
| Q3 25 | $233.3M | $-40.6M | ||
| Q3 24 | $341.7M | — | ||
| Q4 23 | — | $10.9M | ||
| Q3 23 | — | $41.6M | ||
| Q1 23 | — | $41.8M | ||
| Q4 22 | — | $41.5M | ||
| Q3 22 | — | $79.1M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | $271.9M | $175.6M | ||
| Q3 24 | $361.6M | — | ||
| Q4 23 | — | $68.9M | ||
| Q3 23 | — | $87.8M | ||
| Q1 23 | — | $85.5M | ||
| Q4 22 | — | $94.8M | ||
| Q3 22 | — | $117.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-32.3M | $-11.4M |
| Free Cash FlowOCF − Capex | — | $-11.5M |
| FCF MarginFCF / Revenue | — | -889.8% |
| Capex IntensityCapex / Revenue | 0.0% | 8.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-11.4M | ||
| Q3 25 | $-32.3M | $-11.5M | ||
| Q3 24 | $-28.0M | — | ||
| Q4 23 | — | $-15.2M | ||
| Q3 23 | — | $-12.5M | ||
| Q1 23 | — | $-23.5M | ||
| Q4 22 | — | $-19.8M | ||
| Q3 22 | — | $-8.6M |
| Q4 25 | — | $-11.5M | ||
| Q3 25 | — | $-11.5M | ||
| Q3 24 | $-28.0M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | $-12.6M | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | -889.8% | ||
| Q3 25 | — | -859.4% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -3951.4% | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | 8.2% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 31.3% | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
